Hook and thesis
Joby Aviation has become one of the clearest embodiments of the modern speculative growth trade - a well-capitalized company on the cusp of a technology and regulatory inflection, trading near its 52-week low at roughly $4.84. Certification and early commercial revenues are now realistic, not theoretical, and the market has largely priced in slow or failed execution. That disconnect creates an asymmetric opportunity: if Joby nails certification and a measured commercial launch, upside is material; if it stalls, downside is contained relative to earlier peaks.
My trade thesis is straightforward: buy Joby at $4.84 with a target of $8.00 and a stop at $3.50, using a long-term horizon of 180 trading days. This is not a momentum scalp. It is a patient option on execution, regulatory progress and initial revenue scaling. Technicals are supportive for an entry today - RSI is deeply oversold - but the trade requires tolerance for headline volatility and potential dilution.
What Joby does and why the market should care
Joby Aviation develops an all-electric vertical takeoff and landing (eVTOL) aircraft designed for short urban and regional passenger flights. The company has moved beyond pure R&D: it has logged significant flight miles in testing, is advancing through FAA type certification, and has supplemented development with the acquisition of Blade Air Mobility's helicopter business to bring immediate cash-generating operations into the fold. That transition from R&D to commercial readiness is the fundamental driver for valuation rerating if executed.
Why investors should care: eVTOLs represent a potentially large new addressable market across urban air mobility, short regional routes, and premium point-to-point services. Joby is positioned as one of the most advanced entrants - partnerships and early revenue help bridge the enormous burn-to-revenue gap that has plagued other names in the space.
Numbers that matter
- Market cap: roughly $4.78 billion.
- Enterprise value: about $4.66 billion.
- Cash on hand: approximately $4.89 billion - a meaningful war chest relative to market cap that supports certification and early manufacturing scale.
- Free cash flow (TTM): negative $743.33 million, underscoring ongoing cash burn through commercialization.
- EPS (TTM): -$0.88, consistent with negative profitability during scale-up.
- Valuation multiples: price-to-sales near 39.5x, reflecting tiny revenue today versus market expectations for future scale.
- Technicals: 10-day SMA $5.396, 50-day SMA $6.657, EMA9 $5.239, RSI 23.27 (oversold), MACD indicating bearish momentum but with a small gap between line and signal.
- Short interest: approximately 127.3 million shares as of 09/30/2026 with ~5.6 days to cover - not extreme, but large enough to amplify volatility around positive catalysts.
Put simply: Joby is well financed for the next stages, but it remains loss-making and priced for success. The cash cushion reduces bankruptcy risk and gives the company runway to get to its first paying passengers, while high valuation multiples reflect that much of the future growth is already priced in.
Valuation framing
At a ~$4.78 billion market cap and enterprise value of ~$4.66 billion, Joby is essentially trading near its cash-adjusted value once you consider the roughly $4.89 billion in cash on the balance sheet. That dynamic explains why market participants are cautious: the firm is capital-intensive with negative free cash flow of ~$743 million. The market is, in effect, valuing Joby primarily on its future operating potential - namely certification, ability to scale manufacturing, and commercial revenue growth.
Compare this to historical context: the stock peaked near $18.77 a year ago and has since fallen over 70% as timelines slipped and growth expectations reset. The current multiple of ~39.5x P/S is astronomical only if revenue does not scale. If Joby demonstrates even modest, recurring revenue through Blade and initial eVTOL flights, multiples could compress into a range more commensurate with high-growth aerospace peers, making the current valuation appear conservative in hindsight.
Catalysts to watch
- FAA type certification milestones - each decisive regulatory green light materially derisks the business model and should trigger meaningful rerating.
- First paying passenger flights - operational proof points will shift narrative from speculative to commercial. Analysts expect initial commercial operations before the end of 2026; any confirmation of paying flights will be a major positive.
- Revenue ramp from Blade acquisition - Blade added near-term helicopter revenue estimated at ~$36 million in Q2 2026; consistent growth here improves near-term cash generation.
- Manufacturing scale and cost guidance - evidence that Joby can produce at scale with improving per-unit economics would heavily influence valuation.
- Partnership deployments - activation or expansion of partnerships (e.g., airline or ride-share partners) would validate demand assumptions.
Trade plan (actionable)
Entry: Buy at $4.84.
Target: $8.00.
Stop: $3.50.
Horizon: Long term (180 trading days). I expect this trade to require patience through certification headlines, operational teething and periodic volatility. The 180 trading day horizon gives time for one or more certification milestones and early commercial flight proof points to materialize.
Why this setup: the deep technical oversold condition (RSI ~23) offers a sensible entry point near the 52-week low ($4.43). The stop at $3.50 preserves capital if near-term execution or financing leaves the company damaged; the $8.00 target assumes certification progress and first commercial steps begin translating into clear revenue guidance and a partial re-rating toward growth comparables.
Risks and counterarguments
- Certification delays or unfavorable findings. FAA type certification is the single biggest binary risk. Delays or additional required modifications would push timelines and increase cash burn.
- Continued high cash burn and potential dilution. Negative free cash flow (~$743 million) means Joby could require additional capital before substantial positive cash flow - dilution would hurt existing shareholders.
- Execution risk on manufacturing scale. Moving from prototypes to repeatable production is hard. Cost overruns or slow yield improvements would compress margins and delay revenue.
- Demand and unit economics uncertainty. Even if certified, actual commercial demand, pricing power and operating costs will determine profitability; assumptions about a large, ready market may prove optimistic.
- Competition and technology risk. Multiple well-funded peers and potential incumbents in aerospace could create pricing pressure or regulatory complications.
Counterargument: Critics say Joby is still a speculative ticket on a futuristic mode of transport and that the street is right to value near-zero revenue today. If Joby fails to convert certification progress into predictable, scalable revenue within the next 12-18 months, the current valuation would be hard to justify and downside could accelerate toward prior lows. That is a reasonable view.
Why I disagree (partially): Joby’s balance sheet strength, Blade acquisition revenue contribution, and visible flight-testing progress materially reduce the probability of a catastrophic outcome. The company’s cash position roughly equals current market cap, which creates a margin-of-safety that wasn’t present at higher prices. Put another way, the market is pricing very little for the company’s commercial potential — a controlled execution path could produce a large percentage gain even if ultimate upside is less than early bulls hope.
What would change my mind
- If Joby announces a multi-quarter delay on FAA type certification or new structural modifications that materially increase capex and OPEX, I would exit the trade or tighten stops.
- If the company issues a significant equity raise at a steep discount, that would be a negative catalyst for the thesis unless proceeds are clearly earmarked for near-term revenue generation with commensurate guidance.
- If Joby provides clear, repeatable production metrics and early paying-passenger revenue that beat conservative expectations, I would increase the target and consider removing the stop to let the trade run.
Conclusion
Joby Aviation is a classic patient-growth trade: materially oversold, well-funded and with discrete near-term catalysts that could compress risk and reprice the stock. My recommended play is a disciplined long with entry at $4.84, target $8.00 and stop $3.50, held over a 180 trading day horizon to allow regulatory and commercial developments to play out. This is not a low-risk trade - it is a structured, asymmetric bet that requires disciplined sizing and emotional tolerance for headline-driven volatility. If certification and initial commercial flights progress as expected, the reward-to-risk looks compelling from these levels.
Trade idea snapshot: Entry $4.84 | Target $8.00 | Stop $3.50 | Direction: Long | Horizon: Long term (180 trading days)